CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Increase (Decrease) in Accrued Taxes Payable
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Increase (Decrease) in Accrued Taxes Payable of -$1.80 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedTaxesPayable · last filed 2017-02-14
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued taxes payable for the quarter ending 2016-12-31 was $3.87M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued taxes payable for the quarter ending 2016-09-24 was -$2.60M, a 154.20% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued taxes payable for the quarter ending 2016-06-25 was $10.57M, a 24.16% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued taxes payable for the quarter ending 2016-03-26 was -$13.65M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued taxes payable for fiscal 2016 was -$1.80M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued taxes payable for fiscal 2015 was -$3.91M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued taxes payable for fiscal 2014 was -$7.09M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in accrued taxes payable for fiscal 2013 was -$3.05M, a 231.02% decline from fiscal 2012.
| Period end | Increase (Decrease) in Accrued Taxes Payable 3 month | Increase (Decrease) in Accrued Taxes Payable 6 month | Increase (Decrease) in Accrued Taxes Payable 9 month | Increase (Decrease) in Accrued Taxes Payable 12 month |
|---|---|---|---|---|
| 2016-12-31 | $3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $1.27M derived: sum of 2 quarters · filed 2017-02-14 | $11.85M derived: sum of 3 quarters · filed 2017-02-14 | -$1.80M 10-K · filed 2017-02-14 |
| 2016-09-24 | -$2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $7.98M derived: sum of 2 quarters · filed 2016-11-02 | -$5.67M 10-Q · filed 2016-11-02 | -$7.67M derived: sum of 4 quarters · filed 2017-02-14 |
| 2016-06-25 | $10.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$3.08M 10-Q · filed 2016-08-03 | -$5.08M derived: sum of 3 quarters · filed 2017-02-14 | -$285.00K derived: sum of 4 quarters · filed 2017-02-14 |
| 2016-03-26 | -$13.65M 10-Q · filed 2016-05-04 | -$15.65M derived: sum of 2 quarters · filed 2017-02-14 | -$10.86M derived: sum of 3 quarters · filed 2017-02-14 | $3.08M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-12-26 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $2.79M derived: sum of 2 quarters · filed 2017-02-14 | $16.73M derived: sum of 3 quarters · filed 2017-02-14 | -$3.91M 10-K · filed 2017-02-14 |
| 2015-09-26 | $4.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $18.73M derived: sum of 2 quarters · filed 2016-11-02 | -$1.91M 10-Q · filed 2016-11-02 | -$5.04M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-27 | $13.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$6.70M 10-Q · filed 2016-08-03 | -$9.83M derived: sum of 3 quarters · filed 2017-02-14 | -$6.98M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-28 | -$20.64M 10-Q · filed 2016-05-04 | -$23.78M derived: sum of 2 quarters · filed 2017-02-14 | -$20.93M derived: sum of 3 quarters · filed 2017-02-14 | -$11.23M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-27 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$288.00K derived: sum of 2 quarters · filed 2017-02-14 | $9.41M derived: sum of 3 quarters · filed 2017-02-14 | -$7.09M 10-K · filed 2017-02-14 |
| 2014-09-27 | $2.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $12.54M derived: sum of 2 quarters · filed 2015-11-04 | -$3.95M 10-Q · filed 2015-11-04 | $2.55M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-28 | $9.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$6.80M 10-Q · filed 2015-07-30 | -$299.00K derived: sum of 3 quarters · filed 2016-02-12 | -$5.56M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-29 | -$16.50M 10-Q · filed 2015-04-30 | -$9.99M derived: sum of 2 quarters · filed 2016-02-12 | -$15.26M derived: sum of 3 quarters · filed 2016-02-12 | -$12.61M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-28 | $6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $1.24M derived: sum of 2 quarters · filed 2016-02-12 | $3.88M derived: sum of 3 quarters · filed 2016-02-12 | -$3.05M 10-K · filed 2016-02-12 |
| 2013-09-28 | -$5.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$2.62M derived: sum of 2 quarters · filed 2014-10-30 | -$9.56M 10-Q · filed 2014-10-30 | -$14.55M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-29 | $2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$4.29M 10-Q · filed 2014-08-07 | -$9.28M derived: sum of 3 quarters · filed 2015-02-17 | -$4.70M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-30 | -$6.94M 10-Q · filed 2014-04-30 | -$11.93M derived: sum of 2 quarters · filed 2015-02-17 | -$7.34M derived: sum of 3 quarters · filed 2015-02-17 | $2.71M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-29 | -$4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$406.00K derived: sum of 2 quarters · filed 2015-02-17 | $9.65M derived: sum of 3 quarters · filed 2015-02-17 | $2.33M 10-K · filed 2015-02-17 |
| 2012-09-29 | $4.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $14.64M derived: sum of 2 quarters · filed 2013-10-30 | $7.32M 10-Q · filed 2013-10-30 | $14.74M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $10.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $2.74M 10-Q · filed 2013-07-31 | $10.15M derived: sum of 3 quarters · filed 2014-02-25 | $13.23M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | -$7.32M 10-Q · filed 2013-05-08 | $94.00K derived: sum of 2 quarters · filed 2014-02-25 | $3.17M derived: sum of 3 quarters · filed 2014-02-25 | $2.26M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $7.41M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $10.49M derived: sum of 2 quarters · filed 2014-02-25 | $9.58M derived: sum of 3 quarters · filed 2014-02-25 | -$13.78M 10-K · filed 2014-02-25 |
| 2011-09-24 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $2.17M derived: sum of 2 quarters · filed 2012-11-01 | -$21.20M 10-Q · filed 2012-11-01 | |
| 2011-06-25 | -$909.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$24.27M 10-Q · filed 2012-08-07 | ||
| 2011-03-26 | -$23.36M 10-Q · filed 2012-05-04 | |||
| 2010-12-25 | $13.09M 10-K · filed 2013-02-27 | |||
| 2009-12-26 | -$15.10M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |